TrialCancer chemotherapy and pharmacology2011

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.

Yasunari Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.